Simplex Trading
LEGN icon

Simplex Trading’s Legend Biotech LEGN Stock Holding History

Simplex Trading’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,432
Closed -$561K – 9655
2025
Q4 		$640K Buy
+29,432
New +$843K ﹤0.01% 3059
2025
Q3 		– Sell
-10,371
Closed -$383K – 9578
2025
Q2 		$368K Buy
10,371
+1,847
+22% +$59.9K ﹤0.01% 3841
2025
Q1 		$289K Sell
8,524
-1,786
-17% -$64.1K ﹤0.01% 3951
2024
Q4 		$335K Buy
+10,310
New +$427K ﹤0.01% 3948
2024
Q3 		– Sell
-6,151
Closed -$328K – 9070
2024
Q2 		$272K Buy
+6,151
New +$284K ﹤0.01% 4334
2024
Q1 		– Sell
-704
Closed -$42.5K – 9388
2023
Q4 		$42K Buy
+704
New +$44.6K ﹤0.01% 6255
2022
Q2 		– Sell
-1,681
Closed -$71K – 10569
2022
Q1 		$61K Buy
+1,681
New +$66.4K ﹤0.01% 6854
2021
Q4 		– Sell
-2,003
Closed -$102K – 10968
2021
Q3 		$83K Hold
2,003
– – ﹤0.01% 6884
2021
Q2 		$82K Buy
2,003
+1,984
+10,442% +$67.4K ﹤0.01% 7013
2021
Q1 		$0 Buy
+19
New +$518 ﹤0.01% 9448

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Simplex Trading's LEGN Position: Q1 2026 in Review

Simplex Trading sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 29,432 shares — an estimated $561K sold.

Simplex Trading first reported a position in LEGN in Q1 2021 and held it in 10 quarters. The position peaked at $640K in Q4 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Simplex Trading reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 29,432 Legend Biotech shares in Q1 2026, an estimated $561K.
  • Simplex Trading first reported a position in Legend Biotech in Q1 2021 and held it in 10 quarters.
  • Simplex Trading's Legend Biotech position peaked at $640K in Q4 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.